Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Most Recent Videos

Saudi King Salman Puts His Own Stamp on Government
27:48 - Jan. 30 -- After just one week on the throne, Saudi Arabia’s new king has made some changes to the government, bringing in some of his own people and replacing key security and economic officials. Bloomberg’s Elliott Gotkine reports on “Countdown.”
  • Chizhov: Sanctions Aren’t Working
  • Tsipras to E.U.: No Surprises From Greece
  • PBOC Liquidity May Lead to Asia Stocks Rally: Le Cornu